Lexeo Therapeutics, Inc. - 10-Q Filing

Lexeo Therapeutics reports Q3 financial results including significant research and development expenses and updates on financing transactions.

SEC EDGAR ·

Tickers: $LXEO

Read the full article at SEC EDGAR

More Regulatory news